Senior VP
Mr. Michael Chan is Vice President of the Global Markets Division of Hong Kong Exchanges and Clearing Limited (“HKEx”). Michael is mainly focused on attracting international companies to list in Hong Kong. In addition to leading the marketing efforts globally and working closely with prospects and constituents, Michael often speaks and serves as panelist and keynote speaker at major conferences and events locally and internationally. Prior to his current role, Michael has worked at the Listing Division of HKEx for 7 years managing and monitoring corporate governance, compliance, regulatory and listing-related matters of listed companies. He has established and maintained regular contacts with listed issuers, regulatory and governmental bodies, advisers and market practitioners. Prior to joining HKEx, Michael has worked at various financial institutions in corporate finance and business development. Michael has more than 15 years of experience in financial services and regulatory work and is a BSc graduate of the University of Edinburgh and a post-graduate in law from the College of Law (London).

Emerging Opportunities in Global Markets

11:45 AM–5:00 PM Jun 4, 2018

Room 253ABC, Level 2

Katherine AndersenHead of Healthcare Corporate Finance and East/Central Life Science atSilicon Valley Bank Michael ChanSenior VP atHKEX Helen ChenManaging Director, Head of L.E.K. China and Asia Life Sciences atL.E.K. Consulting Tony ChenPartner atJones Day Shanghei Joseph DamondExecutive Vice President, International Affairs atBiotechnology Innovation Organization Yuan-Hua DingExecutive Director and Head of External Science & Innovation atPfizer Monica H.Director, International Affairs atBiotechnology Innovation Organization Edward HuChief Financial Officer and Chief Investment Officers atWuXi AppTec Kewen JinManaging Partner atSerica Partners Alex JungPartner/Managing DIrector atEY-Parthenon Wei LiFounding Partner at6 Dimensions Capital Micah MackisonSenior VP for Corporate Development and Strategy atAssembly Biosciences Wendy PanPartner atSidley Donghui QinDirector of Innovation atFerring Pharmaceuticals Greg ScottFounder and Chairman atChinaBIO Group Victor ShiChairman atBayHelix Alan TurleyDeputy Assistant Secretary for China atU.S. Department of Commerce Jonathan WangSenior VP and Head of Business Development atZai Lab Lijun WuChief Scientific Officer and Senior VP R&D, Fosun Pharma USA atFosun Pharma USA Haishan XiongSenior Vice President for Business Development atFountain Medical Development, Ltd GE YanfengDirector-General of the Research Department of Social Development atDevelopment Research Center of the State Council (DRC) Debra YuManaging Director atChina Renaissance Securities (US) Inc.